Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience.


Journal

Clinical trials (London, England)
ISSN: 1740-7753
Titre abrégé: Clin Trials
Pays: England
ID NLM: 101197451

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 23 4 2019
medline: 11 7 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

To establish recruitment approaches that leverage electronic health records in multicenter prediabetes/diabetes clinical trials and compare recruitment outcomes between electronic health record-supported and conventional recruitment methods. Observational analysis of recruitment approaches in the vitamin D and type 2 diabetes (D2d) study, a multicenter trial in participants with prediabetes. Outcomes were adoption of electronic health record-supported recruitment approaches by sites, number of participants screened, recruitment performance (proportion screened who were randomized), and characteristics of participants from electronic health record-supported versus non-electronic health record methods. In total, 2423 participants were randomized: 1920 from electronic health record (mean age of 60 years, 41% women, 68% White) and 503 from non-electronic health record sources (mean age of 56.9 years, 58% women, 61% White). Electronic health record-supported recruitment was adopted by 21 of 22 sites. Electronic health record-supported recruitment was associated with more participants screened versus non-electronic health record methods (4969 vs 2166 participants screened), higher performance (38.6% vs 22.7%), and more randomizations (1918 vs 505). Participants recruited via electronic health record were older, included fewer women and minorities, and reported higher use of dietary supplements. Electronic health record-supported recruitment was incorporated in diverse clinical environments, engaging clinicians either at the individual or the healthcare system level. Establishing electronic health record-supported recruitment approaches across a multicenter prediabetes/diabetes trial is feasible and can be adopted by diverse clinical environments.

Identifiants

pubmed: 31007049
doi: 10.1177/1740774519839062
pmc: PMC6764596
mid: NIHMS1522970
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
Cholecalciferol 1C6V77QF41

Banques de données

ClinicalTrials.gov
['NCT01942694']

Types de publication

Clinical Trial Protocol Journal Article Multicenter Study Observational Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-315

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK098245
Pays : United States
Organisme : NIDDK NIH HHS
ID : U34 DK091958
Pays : United States

Références

Control Clin Trials. 2002 Apr;23(2):157-71
pubmed: 11943442
J Am Med Inform Assoc. 2009 Nov-Dec;16(6):869-73
pubmed: 19717797
Clin Trials. 2015 Feb;12(1):77-83
pubmed: 25475878
Clin Diabetes. 2018 Jan;36(1):14-37
pubmed: 29382975
BMJ Open. 2013 Feb 07;3(2):
pubmed: 23396504
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
Diabetes Care. 2014 Dec;37(12):3227-34
pubmed: 25205139
Mil Med. 2017 Mar;182(3):e1580-e1587
pubmed: 28290928
Diabetes Spectr. 2015 May;28(2):99-105
pubmed: 25987808
BMC Med Inform Decis Mak. 2013 Mar 21;13:37
pubmed: 23514203

Auteurs

Vanita R Aroda (VR)

1 MedStar Health Research Institute, Hyattsville, MD, USA.
2 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Patricia R Sheehan (PR)

3 Tufts Medical Center, Boston, MA, USA.

Ellen M Vickery (EM)

3 Tufts Medical Center, Boston, MA, USA.

Myrlene A Staten (MA)

4 KGS for The National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.

Erin S LeBlanc (ES)

5 Kaiser Permanente Center for Health Research NW, Portland, OR, USA.

Lawrence S Phillips (LS)

6 Atlanta VA Medical Center, Decatur, GA, USA.
7 Emory University School of Medicine, Atlanta, GA, USA.

Irwin G Brodsky (IG)

8 Maine Medical Center, Scarborough, ME, USA.

Chhavi Chadha (C)

9 HealthPartners, Minneapolis, MN, USA.

Ranee Chatterjee (R)

10 Duke University School of Medicine, Durham, NC, USA.

Miranda G Ouellette (MG)

11 University of Kansas Medical Center, Kansas City, KS, USA.
12 Georgia Department of Public Health, Atlanta, GA, USA.

Cyrus Desouza (C)

13 University of Nebraska Medical Center, Omaha, NE, USA.

Anastassios G Pittas (AG)

3 Tufts Medical Center, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH